Last reviewed · How we verify
Diuretic initiation or augmentation
Diuretic initiation or augmentation is a Small molecule drug developed by VA Office of Research and Development. It is currently FDA-approved.
At a glance
| Generic name | Diuretic initiation or augmentation |
|---|---|
| Sponsor | VA Office of Research and Development |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Diuretics and Volume Overload in Early CKD (PHASE4)
- Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diuretic initiation or augmentation CI brief — competitive landscape report
- Diuretic initiation or augmentation updates RSS · CI watch RSS
- VA Office of Research and Development portfolio CI
Frequently asked questions about Diuretic initiation or augmentation
What is Diuretic initiation or augmentation?
Diuretic initiation or augmentation is a Small molecule drug developed by VA Office of Research and Development.
Who makes Diuretic initiation or augmentation?
Diuretic initiation or augmentation is developed and marketed by VA Office of Research and Development (see full VA Office of Research and Development pipeline at /company/va-office-of-research-and-development).
What development phase is Diuretic initiation or augmentation in?
Diuretic initiation or augmentation is FDA-approved (marketed).
Related
- Manufacturer: VA Office of Research and Development — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing